According to Genmab's latest financial reports the company's current EPS (TTM) is โน85.95. In 2022 the company made an earnings per share (EPS) of โน99.42 an increase over its 2021 EPS that were of โน61.35.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน82.36 | -17.16% |
2022 | โน99.42 | 62.07% |
2021 | โน61.35 | -35.78% |
2020 | โน95.53 | 119.14% |
2019 | โน43.59 | 36.35% |
2018 | โน31.97 | 29.83% |
2017 | โน24.63 | 0.92% |
2016 | โน24.40 | 47.69% |
2015 | โน16.52 | 109.32% |
2014 | โน7.89 | 134.03% |
2013 | โน3.37 | -121.08% |
2012 | -โน16.00 | -23.69% |
2011 | -โน20.97 | 94.77% |
2010 | -โน10.76 | -70.48% |
2009 | -โน36.46 |